General toxicity and peripheral nerve alterations induced by chronic vincristine treatment in the rabbit.
The effects of five 0.3 mg/kg intravenous administrations of vincristine (VCR) at weekly intervals were studied in the rabbit. Body weight gain was impaired starting from the first injection, while gross signs of motor paralysis and hair loss initiated from the third week. At the end of the observation period blood analysis revealed normocytic normochromic anemia, elevated serum creatine kinase, and low serum alkaline phosphatase, whereas all the tested parameters related to liver and kidney functions where within normal limits. The decreased number of red blood cells was the consequence of a complete, although reversible, blockade of staminal hematopoietic activity. Two important indexes of peripheral nerve function were clearly altered at the end of the treatment: (i) the sciatic nerve conduction velocity in vitro was 27% reduced and (ii) the latency between sciatic nerve stimulation and extensor digitorum longus (EDL) twitch in vivo was 34% prolonged. The usefulness of the rabbit as an animal model to study side-effects of VCR treatment is discussed.
Norido
F
F
Fidia Research Laboratories, Abano Terme, Italy.
Finesso
M
M
Fiorito
C
C
Marini
P
P
Favaro
G
G
Fusco
M
M
Tessari
F
F
Prosdocimi
M
M
D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001773:Blood Cells / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009431:Neural Conduction; D009638:Norepinephrine / Q000032:analysis; D010525:Peripheral Nerves / Q000187:drug effects*; D011817:Rabbits; D014649:Vas Deferens / Q000032:analysis / Q000187:drug effects; D014750:Vincristine / Q000633:toxicity*
D014750:Vincristine; D000469:Alkaline Phosphatase; D009638:Norepinephrine